122 related articles for article (PubMed ID: 1899160)
1. HLA-DR1, -DR5, and -DR8 antigen disparities are associated with acute steroid-resistant rejection and poor kidney graft survival.
Salmela K; von Willebrand E; Kyllönen L; Koskimies S; Isoniemi H; Eklund B; Höckerstedt K; Ahonen J
Transplant Proc; 1991 Feb; 23(1 Pt 2):1272-3. PubMed ID: 1899160
[No Abstract] [Full Text] [Related]
2. The association of HLA-DR antigens with acute steroid-resistant rejection and poor kidney graft survival.
Salmela K; von Willebrand E; Kyllönen L; Koskimies S; Isoniemi H; Eklund B; Höckerstedt K; Ahonen J
Transplantation; 1991 Apr; 51(4):768-71. PubMed ID: 2014528
[TBL] [Abstract][Full Text] [Related]
3. Effect of HLA matching on graft survival in live donor kidney transplantations.
Velidedeoğlu E; Bilgin N; Haberal M
Transplant Proc; 1993 Dec; 25(6):3144-5. PubMed ID: 8266491
[No Abstract] [Full Text] [Related]
4. The effect of induction ALG (MALG) on the outcome of steroid-resistant rejection treated with OKT3 in renal transplant patients.
Chiu A; Landsberg D; Cameron EC; Manson AD; Shackleton C
Transplant Proc; 1991 Feb; 23(1 Pt 2):1039-40. PubMed ID: 1899146
[No Abstract] [Full Text] [Related]
5. Reversal of steroid- and antithymocyte globulin-resistant acute rejection crises in renal transplantation with monoclonal antibody (OKT3).
Prieto C; Rodriguez-Paternina E; Andrés A; Morales JM; Farias J; Montoyo C; Regueiro JR; Rodicio JL
Transplant Proc; 1990 Aug; 22(4):1753-4. PubMed ID: 2117798
[No Abstract] [Full Text] [Related]
6. OKT3 in severe early rejection: predictors for reversal in renal transplant recipients.
Sumrani N; Delaney V; Rajpoot D; Tejani A; Butt K; Hong J
Transplant Proc; 1990 Aug; 22(4):1750-2. PubMed ID: 2117797
[No Abstract] [Full Text] [Related]
7. The treatment of steroid-resistant renal allograft rejection with OKT3 and plasmapheresis.
Haberal M; Sert S; Gülay H; Arslan G; Bilgin N
Transplant Proc; 1990 Aug; 22(4):1761-3. PubMed ID: 2117801
[No Abstract] [Full Text] [Related]
8. Influence of donor/recipient HLA-DR antigen disparities on cadaver kidney graft survival: an alternative for recipient selection.
Vereerstraeten P; Andrien M; Dupont E; Kinnaert P; Toussaint C
Transplant Proc; 1989 Feb; 21(1 Pt 1):679-81. PubMed ID: 2650220
[No Abstract] [Full Text] [Related]
9. Immune responsiveness.
Cook DJ
Clin Transpl; 1988; ():357-63. PubMed ID: 3154485
[TBL] [Abstract][Full Text] [Related]
10. Effect of the HLA-DRw6 antigen in liver transplantation.
Saito S; Stratta RJ; Grazi GL; Castaldo P; Langnas AN; Wood RP; Shaw BW
Transplant Proc; 1991 Feb; 23(1 Pt 2):1430-1. PubMed ID: 1824899
[No Abstract] [Full Text] [Related]
11. Treatment of steroid resistant acute rejection after renal transplantation.
Oh CK; Kim YS; Kim MS; Kim SI; Park K
Transplant Proc; 1996 Jun; 28(3):1453-4. PubMed ID: 8658737
[No Abstract] [Full Text] [Related]
12. Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
Troppmann C; Almond PS; Payne WD; Dunn DL; Gores PF; Gruessner RW; Sutherland DE; Matas AJ; Najarian JS
Transplant Proc; 1993 Feb; 25(1 Pt 2):905. PubMed ID: 8442263
[No Abstract] [Full Text] [Related]
13. Preliminary results of a prospectively randomized trial of ALG vs OKT3 for steroid-resistant rejection after renal transplantation in the early postoperative period.
Hesse UJ; Wienand P; Baldamus C; Arns W
Transplant Proc; 1990 Oct; 22(5):2273-4. PubMed ID: 2120814
[No Abstract] [Full Text] [Related]
14. Anti-donor DR103 Immunization in a DRB1*0101 kidney allograft recipient.
Hajji K; Guignier F; Tanter Y; Rifle G; Mousson C
Transplant Proc; 2006 Sep; 38(7):2306-7. PubMed ID: 16980073
[TBL] [Abstract][Full Text] [Related]
15. [Identification of HLA-DR antigenic disparities favorable and unfavorable in renal transplantation].
Vereerstraeten P; Dupont E; Andrien M; Kinnaert P; Toussaint C
Nephrologie; 1989; 10(1):33-8. PubMed ID: 2654687
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR1 recipients have the highest kidney transplant survival.
Cook DJ; Cecka JM; Terasaki PI
Transplant Proc; 1987 Feb; 19(1 Pt 1):675-7. PubMed ID: 3274837
[No Abstract] [Full Text] [Related]
17. HLA-DR1 is a low responsiveness antigen in human kidney transplant recipients.
Cicciarelli J
Clin Transpl; 1987; ():381-91. PubMed ID: 3154437
[TBL] [Abstract][Full Text] [Related]
18. Consequences of anti-OKT3 antibody development: OKT3 reuse and long-term graft survival.
Shield CF
Transplant Proc; 1993 Apr; 25(2 Suppl 1):81-2. PubMed ID: 8465434
[No Abstract] [Full Text] [Related]
19. Transfusion effect still present with quadruple immunosuppression in recipients of renal transplants.
Yang HC; Weaver AS; Gifford RR
Transplant Proc; 1991 Feb; 23(1 Pt 2):1247-8. PubMed ID: 1899159
[No Abstract] [Full Text] [Related]
20. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation.
Chen M; Wade J; Levy GA; Greig PD
Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
